DIAZEPAM TREATMENT DOES NOT INFLUENCE THE DEBRISOQUINE OR MEPHENYTOIN HYDROXYLATION PHENOTYPING TESTS

被引：9

作者：

SPINA, E

BUEMI, AL

SANZ, E

BERTILSSON, L

机构：

[1] KAROLINSKA INST,HUDDINGE HOSP,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN

[2] UNIV MESSINA,INST PHARMACOL,I-98100 MESSINA,ITALY

[3] MENTAL HLTH SERV,MESSINA,ITALY

来源：

THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 06期

关键词：

D O I：

10.1097/00007691-198911000-00019

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：721 / 723

页数：3

共 16 条

[1]

BERLIN A, 1972, CLIN PHARMACOL THER, V13, P733

[2] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J].

BERTILSSON, L ;

HENTHORN, TK ;

SANZ, E ;

TYBRING, G ;

SAWE, J ;

VILLEN, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :348-355

[3] STEADY-STATE CONCENTRATIONS OF IMIPRAMINE AND ITS METABOLITES IN RELATION TO THE SPARTEINE DEBRISOQUINE POLYMORPHISM [J].

BROSEN, K ;

KLYSNER, R ;

GRAM, LF ;

OTTON, SV ;

BECH, P ;

BERTILSSON, L .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (06) :679-684

[4] EXTENSIVE METABOLIZERS OF DEBRISOQUINE BECOME POOR METABOLIZERS DURING QUINIDINE TREATMENT [J].

BROSEN, K ;

GRAM, LF ;

HAGHFELT, T ;

BERTILSSON, L .

PHARMACOLOGY & TOXICOLOGY, 1987, 60 (04) :312-314

[5] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[6]

INABA T, 1985, DRUG METAB DISPOS, V13, P443

[7] GENETIC-VARIATION IN THE HUMAN HEPATIC CYTOCHROME-P-450 SYSTEM [J].

KALOW, W .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 31 (06) :633-641

[8]

KNODELL RG, 1988, J PHARMACOL EXP THER, V245, P845

[9]

KUPFER A, 1985, CLIN PHARMACOL THER, V38, P414

[10] PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN [J].

KUPFER, A ;

PREISIG, R .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :753-759

← 1 2 →